
Lung regeneration
Public sources describe clinical translation/application pathways for selected respiratory conditions. Direct international-access verification is ongoing.
View details →A pathway appears here only when there is a credible clinical basis. “International Access Confirmed” is reserved for services directly verified with the treating institution.

“Approved” can be misleading when it does not explain the regulatory route, current intake or whether foreign patients can apply.
International patients may apply, subject to hospital review.
A clinical pathway is identified, but foreign-patient intake is not yet directly confirmed.
A registered study with separate research rules and eligibility criteria.
Scientific activity exists, but no current clinical access has been verified.

Public sources describe clinical translation/application pathways for selected respiratory conditions. Direct international-access verification is ongoing.
View details →
A cell-based clinical translation/application pathway has been publicly reported. Current foreign-patient intake requires direct confirmation.
View details →
A regenerative clinical translation/application pathway has been publicly reported. Eligibility and international intake remain case-dependent.
View details →Share your diagnosis, current treatment and key recent tests. We will first determine whether a potentially relevant pathway exists and what records a hospital would need.
Submit Your Case →